We also used a hypothesis-driven approach to identify additional kinases involved in regulating receptor intracellular levels by conducting Affymetrix analyses on ERα-positive BC cells treated with telaprevir (Tel), an antiviral drug inducing ERα degradation by inhibiting the kinases IGF1-R and AKT26,27. This evidence concerns the gene IGF1R and breast cancer.